2,309
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Biomarkers for the diagnosis of deep vein thrombosis

, MD & , MD
Pages 253-257 | Published online: 06 Jun 2012

Bibliography

  • Heit JA, Cohen A, Anderson FJ. Estimated annual number of incident and recurrent, non-fatal venous thromboembolism (VTE) events in the US. Blood 2005;106:11
  • Rectenwald JE, Myers DD, Hawley AE, D-Dimer, P-Selectin, and microparticles: novel markers to predict deep venous thrombosis. Thromb Haemost 2005;94:1312-17
  • Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008;28:387-91
  • Cosmi B, Legnani C, Cini M, D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep venous thrombosis. Thromb Haemost 2005;94:969-74
  • Linkins LA, Choi PO, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 2006;139:893-900
  • Kurklinsky AK, Kalsi H, Wysokinski WE, Fibrin D-Dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume. Angiology 2011;62(3):253-6
  • van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002;117:113-22
  • Frenette PS, Moyna C, Hartwell DW, Platelet-endothelial interactions inflamed mesenteric venules. Blood 1998;91:1318-24
  • Frenette PS, Denis CV, Weiss L, P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000;191:1413-22
  • Mayadas TN, Johnson RC, Rayburn H, Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice. Cell 1993;74:541-54
  • Ramacciotti E, Blackburn S, Hawley AE, Evaluation of soluble P-Selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 2011;17(4):425-31
  • del Conde I, Nabi F, Tonda R, Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol 2005;25(5):1065-70
  • Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998;92:4446-52
  • Jilma B, Fasching P, Ruthner C, Hypothesis: is soluble P-selectin a new marker platelet activation? Atherosclerosis 1997;128:135-8
  • Barnes DM, Wakefield TW, Rectenwald JE. Novel biomarkers for deep venous thrombosis: a comprehensive review. Biomark Insights 2008;21(3):93-100
  • Andre P, Hartwell D, Hrachiovinova I, Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97(25):13835-40
  • Myers DD Jr, Henke PK, Bedard PW, Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006;44(3):625-32
  • Gremmel T, Ay C, Seidinger D, Soluble p-selectin, D-dimer and high-sensitivity C-reactive protein after deep vein thrombosis of the lower limb. J Vasc Surg. 2011 Dec;54(6 Suppl):48S-55S
  • Kyrle PA, Hron G, Eichinger S, Circulating p-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 2007;97:880-3
  • Ay C, Simanek R, Vormittag R, High plasma levels of soluble p-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008;112:2703-8
  • Vandy FC, Stabler C, Hawley AE, Soluble P-Selectin for the diagnosis of lower extremity deep venous thrombosis. Presented at the 24th Annual Meeting of the American Venous Forum; February 2012
  • Myers DD, Hawley AE, Farris DM, P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003;38:1075-89
  • Jilma B, Kovar F, Hron G, Homozygosity in the single nucleotide polymorphism Ser126Arg in the E-selectin gene associated with recurrent venous thromboembolism. Arch Intern Med 2006;166:1655-9
  • Falati S, Liu Q, Gross P, Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-98
  • Goel MS, Diamond SL. Neutrophil enhancement of fibrin deposition under flow through plateletdependent and -independent mechanisms. Arterioscler Thromb Vasc Biol 2001;21:2093-8
  • Rectenwald JE, Myers DD, Hawley AE, D-Dimer, P-Selectin, and microparticles: novel markers to predict deep venous thrombosis. Thromb Haemost 2005;94:1312-17
  • Chirinos JA, Heresi GA, Velasquez H, Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45(9):1467-71
  • Bucciarelli P, Martinelli I, Artoni A, Circulating microparticles and risk of venous thromboembolism. Thromb Res 2012 May;129(5):591-7
  • Ramacciotti E, Hawley AE, Wrobleski SK, Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010;125(6):e269-74
  • Hron G, Kollars M, Binder B, Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006;296:397-402
  • Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, Interleukin-10 promoter polymorphism and venous thrombosis—a case control study. ty -45Thromb Haemost 2006;96:24-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.